Related Experiment Video
Updated: Jun 24, 2026

09:33
Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases
Published on: July 28, 2013
White matter involvement in idiopathic Parkinson disease: a diffusion tensor imaging study
G Gattellaro1, L Minati, M Grisoli
1Neuroradiology Unit, Fondazione IRCCS Istituto Nazionale Neurologico Carlo Besta, Milan, Italy.
AJNR. American Journal of Neuroradiology
|April 4, 2009
Summary
Early Parkinson disease (PD) shows widespread white matter damage in the brain, detectable with diffusion tensor imaging (DTI). This microstructural damage affects frontal and parietal regions, indicating early connectivity changes in PD.
Area of Science:
- Neuroimaging
- Neurology
- Biomedical Engineering
Background:
- Parkinson disease (PD) is associated with cognitive symptoms linked to connectivity changes.
- Diffusion Tensor Imaging (DTI) is a neuroimaging technique that can reveal microstructural alterations in the brain's white matter.
Purpose of the Study:
- To assess microstructural damage in the cerebral white matter of patients with idiopathic Parkinson disease.
- To investigate white matter connectivity changes beyond the basal ganglia in early-stage PD.
Main Methods:
- DTI scans were performed on patients with early-stage PD (Hoehn and Yahr stages I-II, no dementia) and age-matched healthy controls.
- Mean diffusivity (MD) and fractional anisotropy (FA) maps were generated.
- Regions of interest (ROIs) were defined on major white matter fiber bundles and deep gray matter nuclei.
Main Results:
- Increased MD was observed in the genu of the corpus callosum and superior longitudinal fasciculus, with decreased FA in these areas.
- Altered MD was found in the cingulum, while FA remained unchanged.
- No significant microstructural changes (MD or FA) were detected in the corticospinal tract, corpus callosum splenium, or basal ganglia nuclei (thalamus, globus pallidus, putamen, caudate).
Conclusions:
- Early-stage Parkinson disease is characterized by widespread microstructural damage in frontal and parietal white matter.
- These findings suggest that white matter integrity is compromised early in the course of PD, potentially contributing to cognitive deficits.
Related Concept Videos
Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...

